( NASDAQ-NMS:AEZS,Toronto:AEZ )

News from aeterna zentaris inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 25, 2015, 13:00 ET Aeterna Zentaris Affirms Fundamental Strength of Business

QUEBEC CITY, Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), affirms that its business and...


Nov 24, 2015, 11:30 ET Aeterna Zentaris Confirms No Corporate Developments

QUEBEC CITY, Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), at the request of IIROC on...


Nov 24, 2015, 08:30 ET Aeterna Zentaris Announces Exercise of Last Series B Warrants Covered by November 1, 2015 Agreement

QUEBEC CITY, Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that the remaining...


Nov 19, 2015, 08:30 ET Aeterna Zentaris Announces First Patient Enrolled for Confirmatory Phase 3 Trial of Macrilen™ for the evaluation of AGHD

QUEBEC CITY, Nov. 19, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZ) (the "Company") announced today that the first...


Nov 18, 2015, 08:30 ET Aeterna Zentaris Announces Details and Implementation of Share Consolidation to Regain NASDAQ Compliance

Common shares to begin trading on a consolidated and reverse-split-adjusted basis on November 20, 2015 QUÉBEC CITY, Nov. 18, 2015...


Nov 16, 2015, 11:44 ET Aeterna Zentaris Announces Shareholder Approval of Share Consolidation

QUÉBEC CITY, Nov. 16, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the...


Nov 12, 2015, 12:54 ET Aeterna Zentaris Announces Exercise of Series B Warrants

QUEBEC CITY, Nov. 12, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that 1,906,451...


Nov 11, 2015, 08:30 ET Aeterna Zentaris Urges Shareholders to Vote in Favor of the Share Consolidation and Highlights Support from ISS and Glass Lewis

All amounts are in US Dollars QUEBEC CITY, Nov. 11, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today...


Nov 02, 2015, 09:30 ET Aeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warrants

All references to dollars are to United States dollars QUEBEC CITY, Nov. 2, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX:...


Oct 27, 2015, 08:30 ET Leading Independent Advisory Firms ISS and Glass Lewis Recommend Shareholders of Aeterna Zentaris Vote FOR Share Consolidation

QUEBEC CITY, Oct. 27, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that Institutional...


Oct 23, 2015, 15:00 ET Aeterna Zentaris to Announce Third Quarter 2015 Financial and Operating Results on November 6, 2015

QUEBEC CITY, Oct. 23, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its third quarter 2015...


Oct 16, 2015, 07:30 ET Aeterna Zentaris Announces Special Meeting of Shareholders and Mailing of Management Information Circular

QUEBEC CITY, Oct. 16, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Corporation") today announced that it has...


Oct 13, 2015, 07:30 ET Aeterna Zentaris: Data and Safety Monitoring Board Recommends Continuation of ZoptEC Phase 3 Trial in Advanced Endometrial Cancer

DSMB's recommendation follows 2nd interim efficacy and safety analysis QUEBEC CITY, Oct. 13, 2015 /PRNewswire/ - Aeterna Zentaris Inc....


Oct 12, 2015, 08:26 ET Aeterna Zentaris Announces Restructuring of Finance & Accounting Operations and Closure of Quebec City Office

QUEBEC CITY, Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical...


Sep 28, 2015, 11:00 ET Aeterna Zentaris' Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint in Men with Heavily Pretreated Castration and Taxane Resistant Prostate Cancer

QUEBEC CITY, Sept. 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its lead...


Sep 25, 2015, 16:30 ET Aeterna Zentaris Announces TSX Approval of Series B Warrant Amendment

All amounts are in US dollars QUEBEC CITY, Sept. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company")...


Sep 24, 2015, 09:00 ET Aeterna Zentaris Announces Dismissal of Class Action Lawsuit

QUEBEC CITY, Sept. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), announced today that the...


Sep 21, 2015, 09:00 ET Aeterna Zentaris Announces Amendment to Series B Warrants

All amounts are in US dollars QUEBEC CITY, Sept. 21, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZ) (the "Company")...


Sep 03, 2015, 07:30 ET Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York

QUÉBEC CITY, Sept. 3, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that...


Aug 13, 2015, 16:15 ET Aeterna Zentaris Reports Second Quarter Financial and Operating Results

Strong fundamentals; pace of transformation accelerates; dilution negatively impacts stock price All amounts are in US Dollars Second quarter key...


Aug 11, 2015, 07:30 ET Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October

QUEBEC CITY, Aug. 11, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the independent Data...


Aug 06, 2015, 07:30 ET Aeterna Zentaris to Announce Second Quarter 2015 Financial and Operating Results on August 13, 2015

QUEBEC CITY, Aug. 6, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its second quarter 2015...


Aug 04, 2015, 07:30 ET Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in Boston

QUÉBEC CITY, Aug. 4, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the...


Jul 29, 2015, 07:30 ET Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development

QUEBEC CITY, July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced it has...


Jul 28, 2015, 07:30 ET Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology

QUEBEC CITY, July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that it...